The US Department of Health and Human Services (HHS) yesterday announced an enhanced nationwide vaccination strategy to mitigate the spread of monkeypox. 29 June 2022
Despite tremendous political-economic challenges that Egypt faced in last two decades, Egypt still remains the largest producer and consumer of pharmaceuticals in the entire Middle East and Africa region with a market value of EGP 56.6billion (US$2.9 billion) in 2022 for pharmaceutical sales. 23 June 2022
The continuous depreciation of the forint, the pandemic, and then the war in Ukraine has seriously endangered safe access to modern medicinal treatments, which is now exacerbated by the disproportionate and high special tax increase that may lead to unforeseen consequences, says the Hungarian pharma trade group Association of Innovative Pharmaceutical Manufacturers (AIPM). 20 June 2022
As the COVID-19 pandemic has prompted multinational pharma corporations to adopt a ‘China Plus One’ strategy, Indian government officials are urging domestic players to take advantage of the opportunity to become a viable alternative to China. 18 June 2022
The Swiss parliament has failed to finance the government's plan to buy COVID-19 vaccines in 2023, forcing the cabinet to try to renegotiate contracts with Moderna and Pfizer/BioNTech’s for millions of doses of their vaccines, according to a report from Reuters. 17 June 2022
Pharma trade group Medicines Australia has moved quickly to ensure that major reform of Australia’s health technology assessment (HTA) system is high on the new government’s agenda. 10 June 2022
The USA’s Federal Trade Commission and the Department of Justice, Antitrust Division, will host a two-day virtual workshop to explore new approaches to enforcing the antitrust laws in the pharmaceutical industry. 1 June 2022
The leading Australian trade body for the pharmaceutical industry, Medicines Australia, said it has alerted “hundreds of key stakeholders to get ready to engage” in the next government review of the country’s health technology assessment (HTA) system. 20 May 2022
In the USA, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded $67.5 million to a consortium of researchers working on pandemic preparedness. 19 May 2022
The European pharma industry has released a new report offering recommendations to improve outcomes for people living with a cardiovascular disease (CVD) in the region. 13 May 2022
Research from industry analyst GlobalData has highlighted the limited impact that Western sanctions have had on foreign innovator drugs in Russia. 22 April 2022
India is well on its way to becoming a global hub for pharmaceuticals. Around 35 active pharmaceutical ingredients (API), which were previously imported into India, are now being manufactured across the country. Applied research for investigational new drugs has also quadrupled in India, reports The Pharma Letter’s India correspondent. 21 April 2022
Trade body Medicines Australia congratulates Senator Anne Ruston on her proposed appointment as Minister for Health and Aging, if the country’s current Coalition is re-elected. 19 April 2022
The European Commission welcomes the swift adoption by the Council of the proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta – markets that have been historically supplied through or by Great Britain. 13 April 2022
The UK is set to become the first country to pay pharmaceutical companies a fixed fee for supplying antibiotics in an effort to tackle the growing global crisis over resistance to the drugs, according to a draft guidance published today by health technology assessor the National Institute of Health and Care Excellence (NICE). 12 April 2022
Unofficial US drug price watchdog the Institute for Clinical and Economic Review (ICER) has published a new white paper in collaboration with researchers at NORC at the University of Chicago. 11 April 2022
The European pharma industry has commissioned a report on drug affordability which highlights its message that overall expenditure on therapies has remained stable. 7 April 2022
According to a report from the US Department of Health and Human Service (HHS) Office of Inspector General (OIG), Biologics - usually large, complex molecules produced in a living system - are some of the most expensive drugs available, and spending for biologics is growing in Medicare Part D because they treat diseases common among Medicare beneficiaries. 4 April 2022
The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will come into force in 2025. 1 October 2024
The Danish government is to remove the rules that currently prohibit the purchase of medicines from countries outside the European Union (EU) in a move that has not been welcomed by pharma. 30 September 2024
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR). 30 September 2024
The generics and biosimilars trade group, Medicines for Europe, has put out a strong message amid ongoing discussions on a European Union (EU) Critical Medicines Act. 26 September 2024
US biotech Emergent BioSolutions revealed it has secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox and mpox product portfolio. 26 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
President Biden has said the USA will commit at least $500 million to support African countries in battling the ongoing mpox outbreak in Central and Eastern Africa. 25 September 2024
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
The Foundation for Economic and Industrial Research and Greek pharma trade group the Hellenic Association of Pharmaceutical Companies have presented two studies reflecting the industry’s importance. 23 September 2024
Basilea Pharmaceutica announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) has awarded Basilea an Other Transaction Agreement (OTA), under OTA number 75A50124C00033. 20 September 2024
Novo Nordisk is under increasing pressure over the cost of its blockbuster drugs in the USA, as chief executive Lars Fruergaard Jørgensen prepares to testify before a powerful Senate committee. 18 September 2024
The research based pharmaceutical industry has welcomed Mario Draghi’s report, published by the European Commission, outlining proposals on how Europe can regain its competitive edge and the critical role of innovative industries in achieving this. 11 September 2024
Even as emerging signs of a thaw in the broader Indian start-up funding landscape were evident, the Competition Commission of India (CCI) has tightened its exemption list under new combination rules. 11 September 2024
The US House of Representatives has passed the BIOSECURE Act, gaining bipartisan support with a vote of 306–81. Nearly all of the votes against the bill came from Democrats. 10 September 2024
The Cell and Gene Therapy Catapult (CGT Catapult) has highlighted what it regards as the UK's potential to lead the global cell and gene therapy sector. 5 September 2024
The budget on October 30 is an opportunity to end short-termism, cut waste, and attract long-term investment to the country’s economy with a sector-targeted R&D tax relief policy, according to the UK BioIndustry Association (BIA). 3 September 2024
The Danish Pharmaceutical Industry Association, Lif, has given its verdict on the government financial bill setting out new priorities in health in 2025. 2 September 2024
Marseille-based ImCheck Therapeutics has received 20.2 million euros ($22.4 million) in non-dilutive funding as part of the i-Démo call for projects under the France 2030 Plan operated by Bpifrance on behalf of the French government. 29 August 2024